Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study

Yıl: 2023 Cilt: 65 Sayı: 1 Sayfa Aralığı: 64 - 72 Metin Dili: İngilizce DOI: 10.24953/turkjped.2021.1132 İndeks Tarihi: 16-05-2023

Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study

Öz:
Background. Coronary arterial lesions (CALs) are the major component of Kawasaki disease (KD), associated with significant morbidity, which affect a substantial proportion of patients despite proper treatment. The aim of this study was to define the risk factors for CALs in Turkish children with KD. Methods. Medical records of 399 KD patients from five pediatric rheumatology centers in Turkey were reviewed retrospectively. Demographic, clinical (including duration of fever before intravenous immunoglobulin [IVIG] and resistance to IVIG), laboratory and echocardiographic data were noted. Results. The patients with CALs were younger, had a higher male ratio and a longer duration of fever before IVIG. They also had higher lymphocyte and lower hemoglobin values before the initial treatment. Multiple logistic regression analyses defined the following three criteria as independent risk factors for predicting CALs in Turkish children with KD: age ≤12 months, male gender and duration of fever before IVIG ≥9.5 days. High sensitivity rates of elevated risk of CALs up to 94.5% were calculated despite specificity values falling to 16.5%, depending on which of these three parameters are taken into account. Conclusions. Based on the demographic and clinical features, we established an easily applicable risk-scoring system for predicting CALs in Turkish children with KD. This may be useful for choosing appropriate treatment and follow-up for KD to prevent coronary artery involvement. Further studies will show whether these risk factors can be used in other Caucasian populations as well.
Anahtar Kelime: coronary arterial involvement intravenous immunoglobulin Kawasaki disease risk factors Turkish children

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. McCrindle BW, Rowley AH, Newburger JW, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017; 135: e927-e999. https://doi. org/10.1161/CIR.0000000000000484
  • 2. Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis 2018; 21: 36-44. https://doi.org/10.1111/1756-185X.13224
  • 3. Conti G, Giannitto N, De Luca FL, et al. Kawasaki disease and cardiac involvement: an update on the state of the art. J Biol Regul Homeost Agents 2020; 34: 47-53.
  • 4. Dedeoglu R, Barut K, Oztunc F, et al. Evaluation of myocardial deformation in patients with Kawasaki disease using speckle-tracking echocardiography during mid-term follow-up. Cardiol Young 2017; 27: 1377-1385. https://doi.org/10.1017/ S1047951117000580
  • 5. Kibata T, Suzuki Y, Hasegawa S, et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin. Int J Cardiol 2016; 214: 209-215. https://doi.org/10.1016/j. ijcard.2016.03.017
  • 6. Liu F, Zhao L, Wu L, et al. Evaluation of treatment and management of Kawasaki coronary artery disease based on clinical severity classification. Zhonghua Er Ke Za Zhi 2015; 53: 690-695.
  • 7. Lo MS, Newburger JW. Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis 2018; 21: 64-69. https://doi. org/10.1111/1756-185X.13220
  • 8. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986; 315: 341-347. https://doi.org/10.1056/NEJM198608073150601
  • 9. Kim SJ. Risk factors related to coronary artery outcome in Kawasaki disease. Korean Circ J 2018; 48: 329-331. https://doi.org/10.4070/kcj.2018.0077
  • 10. McCrindle BW, Li JS, Minich LL, et al; Pediatric Heart Network Investigators. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 2007; 116: 174-179. https:// doi.org/10.1161/CIRCULATIONAHA.107.690875
  • 11. Ruan Y, Ye B, Zhao X. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr Infect Dis J 2013; 32: e397-402. https://doi.org/10.1097/ INF.0b013e31829dd45e
  • 12. Ghelani SJ, Kwatra NS, Spurney CF. Can coronary artery involvement in Kawasaki disease be predicted? Diagnostics (Basel) 2013; 3: 232-243. https://doi.org/10.3390/diagnostics3020232
  • 13. Friedman KG, Gauvreau K, Hamaoka-Okamoto A, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 2016; 5: e003289. https://doi.org/10.1161/ JAHA.116.003289
  • 14. Qiu H, Jia C, Wang Z, et al. Prognosis and risk factors of coronary artery lesions before immunoglobulin therapy in children with Kawasaki disease. Balkan Med J 2020; 37: 324-329. https://doi.org/10.4274/ balkanmedj.galenos.2020.2020.1.56
  • 15. Satoh K, Wakejima Y, Gau M, et al. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method. Int J Rheum Dis 2018; 21: 746-754. https://doi. org/10.1111/1756-185X.13223
  • 16. Son MBF, Gauvreau K, Tremoulet AH, et al. Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population. J Am Heart Assoc 2019; 8: e011319. https://doi.org/10.1161/JAHA.118.011319
  • 17. Jakob A, Schachinger E, Klau S, et al. Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease. Eur J Pediatr 2020; 179: 377-384. https://doi.org/10.1007/s00431-019-03513-6
  • 18. Sato S, Kawashima H, Kashiwagi Y, Hoshika A. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis 2013; 16: 168-172. https://doi.org/10.1111/1756-185X.12082
  • 19. Fabi M, Andreozzi L, Corinaldesi E, et al. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort. Eur J Pediatr 2019; 178: 315-322. https://doi.org/10.1007/s00431- 018-3297-5
  • 20. Azhar AS, Al-Attas A. Risk factors for coronary artery lesions in Kawasaki disease. Med Glas (Zenica) 2013; 10: 254-257.
  • 21. Patel A, Holman RC, Callinan LS, et al. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Acta Paediatr 2013; 102: 385- 390. https://doi.org/10.1111/apa.12142
  • 22. Soriano-Ramos M, Martínez-Del Val E, Negreira Cepeda S, et al. Risk of coronary artery involvement in Kawasaki disease. Arch Argent Pediatr 2016; 114: 107-113. https://doi.org/10.5546/aap.2016.eng.107
  • 23. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991; 33: 805-810. https://doi.org/10.1111/j.1442-200x.1991. tb02612.x
  • 24. Kayiran SM, Dindar A, Gurakan B. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study. Clinics (Sao Paulo) 2010; 65: 1261-1265. https://doi.org/10.1590/s1807- 59322010001200007
  • 25. Ozdemir H, Ciftçi E, Tapisiz A, et al. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. J Trop Pediatr 2010; 56: 260-262. https://doi.org/10.1093/tropej/fmp110
  • 26. Arslanoglu Aydin E, Ertugrul I, Bilginer Y, et al. The factors affecting the disease course in Kawasaki disease. Rheumatol Int 2019; 39: 1343-1349. https:// doi.org/10.1007/s00296-019-04336-2
  • 27. Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease. Turk J Pediatr 2020; 62: 1-9. https://doi.org/10.24953/turkjped.2020.01.001
  • 28. Ayusawa M, Sonobe T, Uemura S, et al; Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 232-234. https://doi. org/10.1111/j.1442-200x.2005.02033.x
  • 29. Sonobe T, Kiyosawa N, Tsuchiya K, et al. Prevalence of coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int 2007; 49: 421-426. https://doi.org/10.1111/j.1442-200X.2007.02396.x
  • 30. Miyata K, Kaneko T, Morikawa Y, et al; Post RAISE group. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study. Lancet Child Adolesc Health 2018; 2: 855-862. https://doi. org/10.1016/S2352-4642(18)30293-1
  • 31. Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 2002; 44: 1-4. https://doi.org/10.1046/j.1442-200x.2002.01508.x
  • 32. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J 2006; 25: 245-249. https://doi.org/10.1097/01. inf.0000202068.30956.16
  • 33. Kim T, Choi W, Woo CW, et al. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 2007; 166: 421-425. https://doi. org/10.1007/s00431-006-0251-8
  • 34. Hua W, Ma F, Wang Y, et al. A new scoring system to predict Kawasaki disease with coronary artery lesions. Clin Rheumatol 2019; 38: 1099-1107. https:// doi.org/10.1007/s10067-018-4393-7
  • 35. Callinan LS, Tabnak F, Holman RC, et al. Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J 2012; 31: 894-898. https://doi.org/10.1097/ INF.0b013e31825c4d7c
  • 36. Fernandez-Cooke E, Barrios Tascón A, Sánchez- Manubens J, et al; KAWA-RACE study group. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group. PLoS One 2019; 14: e0215665. https:// doi.org/10.1371/journal.pone.0215665
  • 37. Bal AK, Prasad D, Umali Pamintuan MA, Mammen- Prasad E, Petrova A. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease. Pediatr Neonatol 2014; 55: 387-392. https:// doi.org/10.1016/j.pedneo.2013.11.007
  • 38. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113: 2606-2612. https://doi.org/10.1161/ CIRCULATIONAHA.105.592865
  • 39. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006; 149: 237-240. https://doi.org/10.1016/j.jpeds.2006.03.050
  • 40. Matsubara T. Infliximab for the treatment of Kawasaki disease. Pediatr Int 2018; 60: 775. https:// doi.org/10.1111/ped.13663
  • 41. Wardle AJ, Connolly GM, Seager MJ, Tulloh RM. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2017; 1: CD011188. https://doi.org/10.1002/14651858. CD011188.pub2
  • 42. Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998; 87: 32-36. https://doi.org/10.1080/08035259850157831
  • 43. Lu CP, Lee WJ, Ho MM, Hwang KC. Risk factors of coronary arterial aneurysm in Kawasaki disease. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1993; 34: 173-180.
  • 44. Maric LS, Knezovic I, Papic N, et al. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience. Rheumatol Int 2015; 35: 1053-1058. https://doi.org/10.1007/ s00296-014-3186-9
APA turkucar s, Kaya Akca Ü, Çakmak F, Haşlak F, demir f, karabulut e, Makay B, Bilginer Y, Aktay Ayaz N, sozeri b, Kasapcopur O, Karagoz T, ÜNAL N, Ozen S, Unsal E (2023). Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. , 64 - 72. 10.24953/turkjped.2021.1132
Chicago turkucar serkan,Kaya Akca Ümmüşen,Çakmak Figen,Haşlak Fatih,demir ferhat,karabulut erdem,Makay Balahan,Bilginer Yelda,Aktay Ayaz Nuray,sozeri betul,Kasapcopur Ozgur,Karagoz Tevfik,ÜNAL NURETTİN,Ozen Seza,Unsal Erbil Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. (2023): 64 - 72. 10.24953/turkjped.2021.1132
MLA turkucar serkan,Kaya Akca Ümmüşen,Çakmak Figen,Haşlak Fatih,demir ferhat,karabulut erdem,Makay Balahan,Bilginer Yelda,Aktay Ayaz Nuray,sozeri betul,Kasapcopur Ozgur,Karagoz Tevfik,ÜNAL NURETTİN,Ozen Seza,Unsal Erbil Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. , 2023, ss.64 - 72. 10.24953/turkjped.2021.1132
AMA turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. . 2023; 64 - 72. 10.24953/turkjped.2021.1132
Vancouver turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. . 2023; 64 - 72. 10.24953/turkjped.2021.1132
IEEE turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E "Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study." , ss.64 - 72, 2023. 10.24953/turkjped.2021.1132
ISNAD turkucar, serkan vd. "Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study". (2023), 64-72. https://doi.org/10.24953/turkjped.2021.1132
APA turkucar s, Kaya Akca Ü, Çakmak F, Haşlak F, demir f, karabulut e, Makay B, Bilginer Y, Aktay Ayaz N, sozeri b, Kasapcopur O, Karagoz T, ÜNAL N, Ozen S, Unsal E (2023). Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turkish Journal of Pediatrics, 65(1), 64 - 72. 10.24953/turkjped.2021.1132
Chicago turkucar serkan,Kaya Akca Ümmüşen,Çakmak Figen,Haşlak Fatih,demir ferhat,karabulut erdem,Makay Balahan,Bilginer Yelda,Aktay Ayaz Nuray,sozeri betul,Kasapcopur Ozgur,Karagoz Tevfik,ÜNAL NURETTİN,Ozen Seza,Unsal Erbil Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turkish Journal of Pediatrics 65, no.1 (2023): 64 - 72. 10.24953/turkjped.2021.1132
MLA turkucar serkan,Kaya Akca Ümmüşen,Çakmak Figen,Haşlak Fatih,demir ferhat,karabulut erdem,Makay Balahan,Bilginer Yelda,Aktay Ayaz Nuray,sozeri betul,Kasapcopur Ozgur,Karagoz Tevfik,ÜNAL NURETTİN,Ozen Seza,Unsal Erbil Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turkish Journal of Pediatrics, vol.65, no.1, 2023, ss.64 - 72. 10.24953/turkjped.2021.1132
AMA turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turkish Journal of Pediatrics. 2023; 65(1): 64 - 72. 10.24953/turkjped.2021.1132
Vancouver turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study. Turkish Journal of Pediatrics. 2023; 65(1): 64 - 72. 10.24953/turkjped.2021.1132
IEEE turkucar s,Kaya Akca Ü,Çakmak F,Haşlak F,demir f,karabulut e,Makay B,Bilginer Y,Aktay Ayaz N,sozeri b,Kasapcopur O,Karagoz T,ÜNAL N,Ozen S,Unsal E "Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study." Turkish Journal of Pediatrics, 65, ss.64 - 72, 2023. 10.24953/turkjped.2021.1132
ISNAD turkucar, serkan vd. "Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study". Turkish Journal of Pediatrics 65/1 (2023), 64-72. https://doi.org/10.24953/turkjped.2021.1132